Login to Your Account



Talecris Opts for $3.1B Merger Instead of IPO

By Donna Young


Thursday, August 14, 2008
Talecris Biotherapeutics Inc. said it is being acquired by Australian firm CSL Ltd. in a $3.1 billion cash merger that would form one of the largest plasma-derived therapeutics firms worldwide. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription